07524501 is referenced by 5 patents and cites 116 patents.

The present invention is directed to VEGF-2 polynucleotides and polypeptides and methods of using such polynucleotides and polypeptides. In particular, provided are methods of treating retinal disorders with VEGF-2 polynucleotides and polypeptides.

Title
Methods of treating an injury to, or disorder of, the eye involving photoreceptor proliferation by administering VEGF2 antibodies
Application Number
11/78507
Publication Number
7524501 (B2)
Application Date
March 14, 2005
Publication Date
April 28, 2009
Inventor
Craig A Rosen
Laytonsville
MD, US
Steven M Ruben
Brookeville
MD, US
Viktor Roschke
Rockville
MD, US
Robert Melder
Boyds
MD, US
Ralph Alderson
Gaithersburg
MD, US
Agent
Sterne Kessler Goldstein & Fox P L L C
Assignee
Human Genome Sciences
MD, US
IPC
A61K 39/00
A61K 39/395
View Original Source